{
    "title": "Novavax expects it can meet U.S. COVID-19 vaccine demand in 2021, executives say",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8613479/Novavax-expects-meet-U-S-COVID-19-vaccine-demand-2021-executives-say.html",
    "date": "2020-08-10",
    "keywords": [
        "vaccine",
        "novavax",
        "trial",
        "carl",
        "odonnell",
        "g",
        "week",
        "stage",
        "use",
        "candidate",
        "safety",
        "profile",
        "abhijith",
        "manufacturing",
        "capacity",
        "demand",
        "company",
        "monday",
        "novel",
        "coronavirus",
        "scale",
        "beginning",
        "investor",
        "call",
        "food",
        "drug",
        "administration",
        "study",
        "phase",
        "september",
        "research",
        "chief",
        "gregory",
        "glenn",
        "latestage",
        "december",
        "nvxcov2373",
        "covid19",
        "novavaxs",
        "officer",
        "john",
        "trizzino",
        "interview",
        "operation",
        "speed",
        "house",
        "program",
        "access",
        "virus",
        "government",
        "july",
        "aim",
        "reporting",
        "york",
        "bengaluru",
        "editing",
        "grebler",
        "grant",
        "mccool",
        "sonya",
        "hepinstall"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}